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Abstract
Background: Type IV collagen is the main component of the basement membrane that gives strength to the
blood–gas barrier (BGB). In mammals, the formation of a mature BGB occurs primarily after birth during alveologenesis
and requires the formation of septa from the walls of the saccule. In contrast, in avians, the formation of the BGB
occurs rapidly and prior to hatching. Mutation in basement membrane components results in an abnormal alveolar
phenotype; however, the specific role of type IV collagen in regulating alveologenesis remains unknown.
Results: We have performed a microarray expression analysis in late chick lung development and found that COL4A1
and COL4A2 were among the most significantly upregulated genes during the formation of the avian BGB. Using
mouse models, we discovered that mutations in murine Col4a1 and Col4a2 genes affected the balance between lung
epithelial progenitors and differentiated cells. Mutations in Col4a1 derived from the vascular component were sufficient
to cause defects in vascular development and the BGB. We also show that Col4a1 and Col4a2 mutants displayed
disrupted myofibroblast proliferation, differentiation and migration. Lastly, we revealed that addition of type IV collagen
protein induced myofibroblast proliferation and migration in monolayer culture and increased the formation of
mesenchymal–epithelial septal-like structures in co-culture.
Conclusions: Our study showed that type IV collagen and, therefore the basement membrane, play fundamental roles
in coordinating alveolar morphogenesis. In addition to its role in the formation of epithelium and vasculature, type IV
collagen appears to be key for alveolar myofibroblast development by inducing their proliferation, differentiation and
migration throughout the developing septum.
Keywords: Type IV collagen, Basement membrane, Blood–gas barrier, Alveolar development, Lung epithelium,
Lung vasculature, Alveolar myofibroblast migration and differentiation
Background
The lung is a complex, precisely structured organ in which
the vascular network is intimately associated with
epithelial-lined tubes and sacs for the prime purpose of
gas exchange. In the developing lung, the specific
temporal-spatial interactions between mesenchymal and
epithelial cells are carefully orchestrated to permit the
gradual establishment of an effective blood–gas barrier
(BGB) [1, 2]. The formation of the mammalian respiratory
unit is initiated during the transition between the pseudo-
glandular and canalicular/saccular stages and is character-
ized by coordinated proliferation and differentiation of
epithelial and mesenchymal cells. During the saccular
stage, the distal tips of the pulmonary airways dilate and
primary septa form. Type I (forming the internal epithelial
(alveolar) layer) and type II pneumocytes continue differ-
entiating from primordial bronchoalveolar cells and the
interstitial mesenchyme becomes thinner [3, 4]. Later, as
alveolarization progresses, secondary septa develop and
the microvascular network matures from a double to a
single capillary network [2, 5, 6].
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The essential components of the BGB were established
early in evolution and are conserved among vertebrates.
Only mammals and birds have a complete separation of
pulmonary and systemic circulations [7]. Despite ana-
tomical differences, the lungs of both species are func-
tional equivalents, so the chick can serve as an effective
experimental surrogate for the formation of the BGB in
mammals (Fig. 1a). In contrast to later postnatal devel-
opment in mammals, the pulmonary BGB in chick
develops primarily in ovo prior to hatching and is char-
acterized by a massive increase in air and blood capillar-
ies, which develop with a progressive reduction of the
lung interstitium [8, 9].
Type IV collagen is the major component of the BGB
epithelial and endothelial basement membranes and is re-
sponsible for its strength [7, 10]. The most widely distrib-
uted form of collagen IV is the isoform [a1(IV)]2,a2(IV)
[11–13]. Homozygous mutations of Col4a1 and Col4a2
(Col4a1–/–; Col4a2–/–) are lethal after mid-embryogenesis
(E10.5–E11.5) because of impaired basement membrane
stability [10]. Heterozygous mutants developed porence-
phaly with severe perinatal cerebral hemorrhage, along
with ocular and renal abnormalities; pups were also often
observed to be cyanotic with respiratory distress, dying
soon after birth [14, 15]. Most Col4a1+/Δex41 heterozygous
mouse mutants with deletion of exon 41 exhibited com-
pact lungs with little or no detectable terminal air spaces
[15]. Col4a1+/Δex41 mutations had been shown to cause an
increase of intracellular accumulation and a decrease of
extracellular collagen, and the decrease of extracellular
type IV collagen might contribute to the abnormal angio-
genesis observed in Col4a1+/Δex41 mutants [16, 17]. Ab-
normalities in vascular development are also observed in
Col4a1–/–; Col4a2–/– mutants [10].
Multiple paracrine signals between epithelium, endo-
thelium and mesenchymal stroma direct alveolar devel-
opment and need to be coordinated to ensure the
proper formation of the BGB at birth [18]. The pulmon-
ary vasculature is essential for alveoli formation, which
is disrupted when angiogenesis is inhibited [19–23].
Equally important are the alveolar myofibroblasts, be-
lieved to direct alveolar septal formation by controlling
elastin synthesis [24, 25]. During alveologenesis, platelet-
derived growth factor receptor alpha (PDGFRα) express-
ing myofibroblast progenitors differentiate into alpha
smooth muscle actin (α-SMA) alveolar myofibroblasts
which are anchored onto the basement membrane [26–29].
Mice with defective myofibroblast differentiation and
proliferation reveal phenotypes of impaired alveolar
development [30–32].
Defective alveolarization is observed in immature
lungs from babies born prematurely or with lung hypo-
plasia, and in chronic lung disease [23, 33–41]. Lung
immaturity is the consequence of the arrest of lung
development between the saccular and the alveolar stages,
whose molecular mechanisms remain unclear despite their
critical role for the formation of the gas exchange unit. Tak-
ing advantage of the rapid avian pulmonary development,
we studied gene expression trends occurring mid to late in
BGB formation using microarrays with COL4A1 and
COL4A2 among the most upregulated genes. Although
mutations in several basement membrane components, in-
cluding Col4a1+/Δex41, have been reported to result in little
or no detectable terminal air spaces [15, 42–44], very little
is known about the role of the basement membrane or col-
lagens in alveologenesis. We found that Col4a1 and Col4a2
mutations caused defects in epithelial, endothelial and mes-
enchymal alveolar patterning that result in an aberrant
BGB combined with defective elastin deposition and septa
formation. Col4a1+/Δex41 conditional expression in vascular
cells was sufficient to cause a disorganized BGB. Finally, we
determined that type IV collagen directs myofibroblast pro-
liferation and migration, and the formation of septal-like
formations in vitro. Type IV collagen appears to control the
epithelial, endothelial and myofibroblast components of the
alveolar unit, thereby permitting adequate gas exchange.
Results
Microarray analysis identifies high COL4A1 and COL4A2
expression at the time of chick BGB formation
Taking advantage of the more rapid in ovo formation of
the avian BGB respiratory units (Fig. 1a), we isolated
RNA from Gallus gallus embryonic lungs at embryonic
days (E)14, 15, 16, and 18, in triplicate. The microarray
data analysis showed 892 significantly differentially
expressed transcripts (P < 0.05), corresponding to 551
unique mouse orthologs listed by Ensembl BioMart. The
differentially regulated genes between E14 and E18 were
annotated by the Mouse Genome Informatics (MGI)
VisuaL Annotation Display (Vlad) tool. The most signifi-
cantly enriched Gene Ontology (GO) categories were
angiogenesis (GO: 0001525) and extracellular matrix
(GO: 0044421, GO: 0044421, GO: 0005615). Vascular
development was among the most prominent processes
at this stage (Additional file 1: Figure S1A–C). Between
E14 and E18, there were 24 vascular up-regulated genes,
11 of which had ANOVA P < 0.02 (Fig. 1b). Interestingly,
the up-regulated genes COL4A1 and COL4A2 were
present across every significant GO category identified
(Additional file 1: Figure S1B). Real time-qPCR con-
firmed the increase of COL4A1 and COL4A2 in the
chick lung during gestation (Fig. 1c).
Col4a1 and Col4a2 are essential in the mouse for saccular
and alveolar growth
We used a number of mouse genetic models to study
the role of type IV collagen during lung organogenesis,
including three distinct mutations from an allelic series
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of Col4a1 and Col4a2 mutations and a Col4a1 condi-
tional allele [17, 45–47]. Mutations from the allelic series
include a point mutation in Col4a1 (Col4a1G394V), a
point mutation in Col4a2 (Col4a2G646D) and a splice site
mutation in Col4a1 that results in a deletion of exon 41
(Col4a1Δex41). In R26-CreER; Col4a1+/Flex41 and Tie2-Cre;
Col4a1+/Flex41 conditional mice, the mutation was gener-
ated by flanking exon 41 with LoxP sites and therefore
recreates the Col4a1Δex41 mutation in a CRE-dependent
manner (called Col4a1Flex41) [17]. Besides having differ-
ent mutations, all of the strains are otherwise genetically
identical.
In normal mouse lungs at E16.5, E18.5, postnatal day
(P)6 and P30, type IV collagen is expressed in the inter-
stitium. COL4A1 localization in the epithelial basement
membrane at the branching tips at E16.5 is almost un-
detectable (Fig. 1d), but it is found in proximal epithe-
lium and also at the tip of secondary septa (Fig. 1d–f ).
Col4a1 mRNA expression was very weak at epithelial
tips and surrounding mesenchyme at E16.5 (Fig. 1h), but
later, at E18.5, P6, and P30, it was clearly found in the
lung interstitium and at the tips of the developing septa
(Fig. 1i–k). Hematoxylin and eosin (H&E) staining of the
lungs of Col4a1+/Δex41 mutants at E16.5 showed no clear
difference in branching morphogenesis compared with
wild type lungs (Fig. 2a, b). Later, at E18.5 (saccular
stage), Col4a1+/Δex41, Col4a1+/G394V and Col4a2+/G646D
displayed lung hypercellularity and thickened interstitia.
Moreover, the tips of the distal airways in lungs from
mutant mice failed to form saccules and primary septa
(Fig. 2c, d and Additional file 2: Figure S2A, B). Surviv-
ing Col4a1+/Δex41 mutants have reduced viability [14];
however, those that survive to P6 and 1 month (P30)
have an emphysematous-like phenotype with simplified
alveolarization and an overall decrease in the number of
secondary septa (Fig. 2e–h). Toluidine blue staining of
lungs from Col4a1+/Δex41 mice also showed alveolar sim-
plification with thick septa (Fig. 2i, j). Closer examin-
ation of Col4a1+/Δex41 lungs showed an increase of blood
capillaries and cells with lipid content (Fig. 2j). Both the
inducible R26-CreER; Col4a1+/Flex41 and vascular endo-
thelial restricted Tie2-Cre; Col4a1+/Flex41 conditional
mutants also showed simplified alveoli formation at P30
(Additional file 3: Figure S3A, B) with R26-CreER;
Col4a1+/Flex41 lungs having a phenotype similar to
Col4a1+/Δex41 lungs. Tie2-Cre; Col4a1+/Flex41 conditional
lungs have numerous blood capillaries, but accumulation
of cells with lipid content in the septa is not observed
(Additional file 3: Figure S3B, D). Electron microscopy
of Col4a1+/Δex41 also showed increased capillaries and
thick interstitium in septa (Fig. 2k, l). Lung septa also
appear to display an excess of elastin fibers (Fig. 2l, n).
Type IV collagen in the mouse regulates distal epithelial
cell proliferation and differentiation during saccular
formation
To investigate whether the lung hypercellularity is the
result of abnormal distal epithelial cell proliferation, we
co-stained E18.5 lungs with the proliferative Ki67 and
the lung epithelial lineage factor NK2 homeobox 1
(NKX2.1) markers. Ki67 at E18.5 showed an overall
increase of cell proliferation (Fig. 3a, b) with little or no
epithelial proliferation, as indicated by NKX2.1 and Ki67
co-localization (Fig. 3c–h; and 48). Next, we studied dis-
tal epithelial differentiation by staining with NKX2.1,
SRY-homeobox 9 (SOX9) and pro-surfactant protein C
(pSPC), and discovered a statistically significant decrease
of SOX9+ progenitor cells (Student’s t test P < 0.05;
Fig. 3i) and an increase of pSPC+ type II pneumocytes
(P < 0.05; Fig. 3i). Real-time PCR of Col4a1+/Δex41 lungs
confirmed decrease of mRNA expression of Sox9 (Wil-
coxon rank-sum test P < 0.05) but not an increase in
pSPC mRNA (Fig. 3j). After alveolarization, an increase
in pSPC+ cells was still observed (Fig. 3k). Morphologic-
ally, Col4a1+/Δex41, Col4a1+/G394V and Col4a2+/G646D had
a patchy distribution with clustering of SOX9+, NKX2.1+
and pSPC+ cells versus normal lungs (Fig. 3l–q and
Additional file 2: Figure S2C–G). At P6 and P30, hetero-
zygous Col4a1+/Δex41 and R26-CreER; Col4a1+/Flex41 mice
still displayed an increase of clustered pSPC+ type II
pneumocytes (Additional file 4: Figure S4D, H, I) that
was not observed in endothelium restricted Tie2-Cre;
Col4a1+/Flex41 mice or in normal siblings (Additional file 4:
Figure S4A, G, J). When, we co-stained Col4a1+/Δex41 lung
sections with pSPC and the type I pneumocyte marker
podoplanin (PDPL), we found that clusters of pSPC+ cells
grouped around a fragmented PDPL at E18 and P6
(Fig. 4a–d). Later, at P30, the alveolar epithelium showed
(See figure on previous page.)
Fig. 1 Lung development timeline and type IV collagen expression in the chicken and the mouse. a Mouse and chicken lung development
comparative timeline. b Microarray analysis shows that vascular related genes, among which are Col4a1 and Col4a2, show the highest significance in
late chick lung development. c Real-time PCR shows differential expression of Col4a1 (blue) and Col4a2 (green) between E16 and E18 in chick lungs.
Col4a1 and Col4a2 expression increases at E16 and E18, and is statistically significant (Wilcoxon rank-sum test P < 0.05) when compared to E14. Chicken
G6PDH was used as a normalizer. d–i Type IV collagen protein and mRNA expression in the lung. d–g COL4A1 protein is found throughout the lung
interstitium and epithelium (arrows) in the prenatal (E18.5) and postnatal (P6, P30) lungs but mainly in the interstitium at E16.5. At P6 and P30 murine
COL4A1 protein is found at the tips of secondary septa (arrowhead in FGF). h–k Col4a1 mRNA is almost undetectable by in situ hybridization at E16.5
(h) and is later found in a patchy distribution throughout the interstitium (arrows in i–k) with high expression at the tips of primary and secondary
septa (arrowheads). Scale bar = 100 μm and applies to d–i
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Fig. 2 Histological examination of Col4a1+/Δex41. a, b Hematoxylin and eosin staining of normal and Col4a1 mutant lungs at E16.5 shows typical
pseudoglandular structures. c At E18.5, normal lungs are composed of dilated distal tubules surrounded by relatively thin mesenchyme with
arising primary septa, which are characteristic of the saccular stage. d Col4a1+/Δex41 lungs have fewer dilated tubules, thick interstitium, and fewer and
shorter primary septa. e Normal alveolar and development at P6, showing secondary septa. f P6 Col4a1+/Δex41 have fewer fully developed alveoli. g At
P30, normal lungs show thin secondary septa and interstitium. h Col4a1+/Δex41 mutant lungs in surviving mice display much fewer secondary septa
and a thicker interstitium. i Toluidine blue staining of Col4a1+/+ semi-thin lung sections show capillaries (arrowheads). j In Col4a1+/Δex41, the septa have
an increase of interstitial blood capillaries (arrowhead) and cells with lipid content (arrows). k–n Electron microscopy of normal and Col4a1+/Δex41
lung septa at P30. m Col4a1+/Δex41 septum showing capillaries (arrowheads), type II pneumocytes (arrows) and elastin fibers (red arrows).
Scale bars = 200 μm in a–d, 35 μm in i, j, and 6 μm in k, l
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Fig. 3 Decreased epithelial progenitors and increased type II pneumocytes in Col4a1+/Δex41. a–j Epithelial proliferation and differentiation were
evaluated by staining with Ki67, NKX2.1, SOX9, and pSPC. a, b Overall proliferation evaluated by Ki67 is increased in Col4a1+/Δex41 lungs. c–h Double
immunohistochemistry for Ki67 and NKX2.1 shows slightly active epithelial proliferation in NKX2.1 cells (arrows) in normal (c–e) or Col4a1+/Δex41 lungs
at E18.5 (f–h). l The bar charts show the percentage NKX2.1, SOX9 progenitors and pSPC+ cells over the total distal area of the lung of Col4a1 and
Col4a2 mutants and wild type mice. Col4a1+/Δex41 mutants have a statistically significant decrease of SOX9 cells and an increase of pSPC type II
pneumocytes, while NKX2.1+ cells are unchanged compared with normal lungs at E18.5. j Real-time PCR of Nkx2.1, Sox9 and pSpc. Only Sox9 mRNA
expression is decreased in Col4a1+/Δex41. Gapdh was used as a normalizer. k The number of pSPC+ cells at P30 is increased in mutant lungs. l, o NKX2.1,
m, p SOX9 and n, q pSPC localization in normal lungs displays a scattered pattern around the saccular walls (arrows), while in Col4a1+/Δex41 mutants
NKX2.1 and pSPC are clustered together (arrows). Scale bars = 200 μm in a, b, 50 μm in c–h, and 200 μm in l–q
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Fig. 4 Abnormal alveolar epithelium and decreased type I pneumocytes in Col4a1+/Δex41. a–g co-staining of pSPC and podoplanin (PDPL).
a, c, e PDPL normally lines the majority of the internal saccular surface and alveoli. b At E18.5, Col4a1+/Δex41 PDPL lined the collapsed saccules, which
are surrounded by clusters of pSPC cells. d, f At P6 and P30, the Col4a1+/Δex41 alveolar epithelium is disorganized, as PDPL and pSPC staining shows.
g Tie2-Cre; Col4a1+/Flex41 mice pSPC cell clustering was absent. h–n HOPX staining in the nucleus and cytosol of type I pneumocytes.
(i, k, m) Col4a1+/Δex41 lungs display fewer nuclear HOPX+ cells (arrows), more prominently at P6 and P30. n Tie2-Cre; Col4a1+/Flex41 lungs show similar
staining to normal lungs. Scale bars = 50 μm in a–g and 200 μm in h–n
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disorganization (Fig. 4e, f). This disorganization was ob-
served in P30 R26-CreER; Col4a1+/Flex41 (Additional file 4:
Figure S3E) but not obvious in Tie2-Cre; Col4a1+/Flex41
(Fig. 4g).
To show abnormalities more clearly in the develop-
ment of type I pneumonocytes, we also stained lung sec-
tions with the HOP homeobox (HOPX) antibody, which
is specific for the nuclei and cytoplasm of type I pneu-
mocytes [48]. Our data showed a decrease in the num-
ber of HOPX+ cells in Col4a1+/Δex41 at E18.5, P6, and
P30 (Fig. 4h–m). P30 Tie2-Cre; Col4a1+/Flex41 lungs
HOPX expression was similar to normal lungs (Fig. 4n)
but it was reduced in R26-CreER; Col4a1+/Flex41 at P30
(Additional file 3: Figure S3F). When Col4a1+/Δex41 mice
were analyzed before the saccular stage, at E16.5, no ap-
parent differences in cellular proliferation, epithelial and
mesenchyme markers were observed (Additional file 5:
Figure S5A–L).
Vascular type IV collagen is necessary for normal of
epithelial and endothelial association
To assess pulmonary microvasculature development in
type IV collagen mutants, we stained endothelial cells
for Cluster of Differentiation 31 (CD31) at E18.5, P6 and
P30. First, we co-stained with CD31 and Ki67 at E18.5,
which confirmed active endothelial proliferation in both
normal and mutant lungs (Fig. 5a–d). At the saccular
stage (E18.5), normal CD31 staining showed an orga-
nized double layer of endothelial cells (Fig. 5i) forming a
lung vascular plexus that develop into a single layer (Fig. 5p)
in close proximity to the alveolar epithelial type I pneumo-
cytes during alveolar maturation (Fig. 5e, i, g, k, m, p). At
E18.5, Col4a1 and Col4a2 mutants showed a tortuous vas-
cular plexus spreading throughout the lung interstitium
(Fig. 5f, j and Additional file 6: Figure S6A, B) which was
exacerbated at P6 (Fig. 5g, h) and at the end of alveolariza-
tion (P30; Fig. 5n, q). Epithelial–endothelial disorganization
was also observed in Tie2-Cre; Col4a1+/Flex41 (Fig. 5o, r)
and in the postnatal-induced R26-CreER; Col4a1+/Flex41
(Additional file 5: Figure S5C, D) mice, indicating that loss
of endothelial-derived type IV collagen is sufficient to dis-
rupt the endothelial–epithelial association.
Type IV collagen regulates myofibroblast proliferation
and migration
We further characterized the lung mesenchyme in
addition to the epithelial and endothelial compartments.
The PDGFRα-expressing pulmonary myofibroblast pro-
genitors that normally decorate the walls of terminal sac-
cules at E18.5 (Fig. 6a), showed an irregular patchy
distribution in Col4a1+/Δex41 (Fig. 6b), Col4a1+/G394V and
Col4a2+/G646D (Additional file 7: Figure S7A, B) mutants.
Pdgfrα mRNA was significantly decreased in Col4a1+/Δex41
lungs (Wilcoxon rank-sum test P < 0.05; Fig. 6i). At P6
and P30, the decrease of PDGFRα+ cells was evident
in Col4a1+/Δex41 (Fig.6c, d and Additional file 8:
Figure S8A, B), but not in the conditional mice R26-CreER;
Col4a1+/Flex41 and in the Tie2-Cre; Col4a1+/Flex41 mutants
(Additional file 8: Figure S8C, D). Differentiated lung
myofibroblasts express specific markers related to their
functional state [29]. During saccular formation, α-SMA
myofibroblasts, normally detected at the tip of primary
septa (Fig. 6e), were decreased in a patchy distribution in
Col4a1 and Col4a2 mutant lungs (Fig. 6f and Additional
file 7: Figure S7E, F). No difference in α-Sma gene expres-
sion was found in Col4a1 mutants (Fig. 6i). At P6, α-SMA
was not observed at the septal tips (Fig. 6g, h). After
alveologenesis, α-SMA+ alveolar myofibroblasts were only
localized at the tips of alveolar ducts (Fig. 6j) [26]. How-
ever, α-SMA+ slender interstitial myofibroblasts were
present in surviving Col4a1+/Δex41 and in R26-CreER;
Col4a1+/Flex41 mice (Fig. 6k and Additional file 3:
Figure S3G), but not in Tie2-Cre; Col4a1+/Flex41 lungs
(Fig. 6l).
Lipofibroblasts are a second type of lung interstitial
fibroblast; therefore, we examined lung lipofibroblasts in
mutants by staining for adipose differentiation-related
protein (ADFP). Lipofibroblasts were found to be mod-
erately increased at P6 and markedly elevated at P30 in
the Col4a1+/Δex41 and in R26-CreER; Col4a1+/Flex41 com-
pared to normal lungs (Additional file 4: Figure S4B, E,
K–M). However, these changes were not observed in
Tie2-Cre; Col4a1+/Flex41 mutants (Additional file 4:
Figure S4N).
To confirm that the increased lipids in mutants are due
to type II pneumocytes and lipofibroblasts, we stained for
macrophage antigen (MAC). P6 Col4a1+/Δex41 lungs
(Additional file 4: Figure S4C, F) showed a slight de-
crease of macrophages that was not so evident at P30
(Additional file 4: Figure S4O, R).
Since the data above suggest a role of type IV collagen
in alveolar myofibroblast proliferation and mobilization,
we investigated myofibroblast proliferation by treating
Normal Human Lung Fibroblast (NHLF) with type IV col-
lagen recombinant protein. α-SMA+, but not α-SMA–,
NHLFs showed a statistically significant increase in prolif-
eration and migration after 48 hours of treatment
(Fig. 6m–o). These results confirm that type IV collagen is
sufficient to induce both myofibroblast proliferation and
migration.
Abnormal expression of tropoelastin and elastin fiber
deposition in type IV collagen mutants
The force necessary for lifting the alveolar crest from
the primary septal wall is thought to be produced by
septal fibers [25, 49], which prompted us to study
tropoelastin and elastin fiber localization in type IV col-
lagen mutants. During saccular formation, the normal
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distal expression of tropoelastin was reduced in Col4a1
and Col4a2 mutants and the elastin fibers were discon-
tinuous and fragmented (Fig. 7a–d and Additional file 7:
Figure S7E–H). Real-time PCR showed a borderline sig-
nificant decrease of tropoelastin in Col4a1 mutants
(Wilcoxon rank-sum test P = 0.07; Fig. 7e). At P6, very lit-
tle expression of tropoelastin was found at alveolar tips
and elastin fibers were abnormally deposited (Fig. 7f–i).
At the end of alveolarization (P30), tropoelastin and elas-
tin fibers were diffuse throughout the lung interstitium
and at the tip of the secondary septa of Col4a1+/Δex41
(Fig. 7j, k, m, n) and in R26-CreER; Col4a1+/Flex41
(Additional file 3: Figure S3H, I). In Tie2-Cre;
Col4a1+/Flex41 mutants, tropoelastin was markedly
Fig. 5 Abnormal microvasculature and endothelial–epithelial association in Col4a1+/Δex41 mice. a–d Co-staining of Ki67 and CD31 shows active
endothelial proliferation (arrows) at E18.5. e Endothelial cells stained with CD31 exhibit the characteristic double capillary layer of the saccular
stage (i). f In contrast, Col4a1+/Δex41 vascular plexus is disorganized within the interstitium and the alveolar epithelium marked with PDPL (j).
Co-localization of PDPL and CD31 shows abnormal development of the blood–gas barrier in Col4a1+/Δex41 at P6 (g, h, k, l) and P30 (m, n, p, q).
o, r Tie2-Cre; Col4a1+/Flex41 mice also show a disorganized endothelium–epithelium association. Scale bars = 20 μm in a–d, and 100 μm in e–h
and m–o
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decreased in the lung interstitium and septal tips (Fig. 7l).
Abnormalities in elastin fiber deposition were less severe
than in the non-conditional mutants (Fig. 7m, o).
Type IV collagen directs epithelial–mesenchymal
association in vitro
To investigate the role of type IV collagen in septation,
we used an epithelial–mesenchymal co-culture model of
alveolar morphogenesis [50]. This model produces peaks
of mesenchymal cells covered by an epithelial lining.
The central core of mesenchymal cells closely resembles
the myofibroblasts seen during alveolar septal develop-
ment in vivo [50]. When MRC-5 fetal mouse mesenchy-
mal cells were co-cultured with human A549 epithelial
cells, septal-like formations appeared after 4–5 days and
reached their maximum after 7 days (Fig. 8a). After type
IV collagen addition, cellular aggregations where larger
(Fig. 8b) and showed strong staining of PDPL, α-SMA+
and type IV collagen proteins (Fig. 8c–j).
Discussion
We performed gene expression profiling at four embry-
onic time points (E14–18) in the chick lung seeking to
uncover molecular regulators contributing to late lung
development and taking advantage of rapid development
of the BGB in the chick. This analysis revealed that
COL4A1 and COL4A2 genes are highly upregulated dur-
ing the late embryonic stages of chick lung development.
These data are consistent with the peaks of expression
of murine Collagen IV at E18 and P7, which correlate
with saccular and alveolar development [51]. Our study
of Col4a1 and Col4a2 mutant mouse lungs revealed
multiple abnormalities in pulmonary alveoli supporting
the importance of type IV collagen in alveolar develop-
ment. The phenotype observed in Col4a1 and Col4a2
mutants is characterized by a block between the saccular
and alveolar stages reminiscent of the severe abnormal-
ities of premature newborns and children with congeni-
tal diaphragmatic hernia.
In this work, we show that murine type IV collagen is
necessary for alveolar patterning and cellular develop-
ment during saccular and alveolar morphogenesis. After
alveolarization, at P30, all the analyzed mutants showed
alveolar simplification with the strongest phenotype in
Col4a1+/Δex41 lungs. Postnatal-induced conditional mu-
tants in R26-CreER; Col4a1+/Flex41 displayed a milder
phenotype than Col4a1+/Δex41 as a result of normal
alveolar progenitor development during saccular devel-
opment. The abnormal phenotype in R26-CreER; Col4a1
+/Flex41 revealed an active role of type IV collagen in
alveolarization that is independent of branching and sac-
cular defects. We also show that Col4a1 mutation car-
ried by the Tie2 promoter in Tie2-Cre; Col4a1+/Flex41
was sufficient in causing microvascular defects without
the epithelial and fibroblast abnormalities observed in
Col4a1+/Δex41 and R26-CreER; Col4a1+/Flex41.
Type IV collagen is found in the basement membranes
of epithelial and interstitial endothelial cells where
alveolar elastin-producing myofibroblasts are anchored
[26, 27]. In addition, normal Col4a1 mRNA expression
is elevated in the lung interstitium and at the tips of the
septa in the mouse after branching morphogenesis. Con-
sequently, it is not surprising that pulmonary epithelial,
vascular and myofibroblast development is affected by
Col4a1 or Col4a2 mutations. At the completion of
branching morphogenesis (E16.5), we did not observe
differences between Col4a1+/Δex41 and Col4a1+/+ lungs.
The absence of branching defects may be because we ana-
lyzed heterozygous mutants in which sufficient levels of
native protein may be enough to carry out branching. Pre-
vious studies have also shown that defects on basement
membrane components affect alveoli formation, but not
branching morphogenesis [43, 44]. In addition, our data
using the postnatal conditional mutants suggests a role of
Col4a in alveologenesis independent of branching.
By the time of saccular (E18.5) morphogenesis, the lungs
from mutant mice had a thick interstitium and failed to
develop normal saccules. We showed that mutant lungs
have a decrease in the number of distal SOX9+ epithelial
(See figure on previous page.)
Fig. 6 Abnormal development of alveolar myofibroblast in Col4a mutants. a Myofibroblast progenitors positive for PDGFRα are normally scattered in
the alveolar walls and at the tips of primitive septa at E18.5 (arrows). b In Col4a1+/Δex41 lungs, PDGFRα myofibroblast progenitors cluster in a patchy
distribution (arrow). c, d In P6 Col4a1+/Δex41, the number of PDGFRα+ is reduced. e, f α-SMA shows a decrease of differentiated alveolar myofibroblasts
at the primary septa and a patchy distribution in Col4a1+/Δex41 (arrow) when compared with normal lungs at E18.5 (arrow). Arrowheads in c point to
red blood cells. g At P6, some α-SMA+ cells normally localize at the tips of developing septa (arrow). h Col4a1+/Δex41 mutants display a decrease in
septal and interstitial α-SMA+ cells. i Real-time PCR at E18.5 shows statistically significant decrease in Pdgfrα mRNA (Wilcoxon ran-sum test
P < 0.05) but not in α-Sma mRNA. Gapdh was used as a normalizer. j At P30, α-SMA is normally localized at the tips of septa in the alveolar ducts
(arrow). k Col4a1+/Δex41 lungs have elongated α-SMA cells in alveolar septa (arrows). l These elongated α-SMA cells are not observed in the vascular
conditional Tie2Cre; Col4a1+/Flex41 mice, where α-SMA+ cells are found only in the vasculature (arrowhead). m–o Cell proliferation and migration of
α-SMA+ NHLFs treated with type IV collagen protein. m Viability assay of α-SMA+ NHLFs treated with human type IV collagen are measured by
absorbance, and show a significant increase in cell proliferation after 2 days of treatment with 5 μg/mL (n = 3). n α-SMA+ NHLF cells also show
accelerated migration. o Type IV collagen-treated cells have a significantly increased migration filled area after 10 hours of removal of insert. Before
insert removal, the cells were grown in type IV collagen for 2 days (n = 3). Scale bars = 100 μm in a, b, e, f, 200 μm in c, d, g, h, j–l, and 35 μm in n
Loscertales et al. BMC Biology  (2016) 14:59 Page 11 of 21
Fig. 7 (See legend on next page.)
Loscertales et al. BMC Biology  (2016) 14:59 Page 12 of 21
progenitors and an increased number of type II pneumo-
cytes in a patchy distribution. This data suggests that type
IV collagen may regulate Sox9, which has been previously
shown to be critical for alveologenesis by controlling the
transition of distal epithelium from proliferation to differ-
entiation [52]. In mutants, a decrease in Sox9 is coincident
with expansion of type II pneumocytes. Defects in epithe-
lial differentiation may also be a consequence of abnormal
basement membrane, which normally undergoes alter-
ation during lung development [53–55]. Starting in the
saccule stage and during alveolarization the basement
membrane is discontinuous under type II pneumocytes
but not under type I [53, 54]. Therefore, it is also possible
that the mutant type IV collagen may affect basement
membrane integrity, altering type II pneumocyte differenti-
ation. Epithelial differentiation defects in mutants are also
supported by the decrease in HOPX cells. Epithelial pro-
genitors express both type I and II pneumocyte markers
[3]. Hence, the increase of pSPC+ cells appears to be a
consequence of differentiation but not of alveolar progeni-
tor proliferation. Increased and disorganized type II
pneumocytes and decreased HOPX were also ob-
served in postnatal Col4a1+/Δex41 and induced R26-CreER;
Col4a1+/Flex41 mice, but not in vascular directed Tie2-Cre;
Col4a1+/Flex41 conditional mutants. These findings indi-
cate that type IV collagen controls epithelial differentiation
and organization independently of vascular type IV
collagen.
It has been shown that mutations in Col4a1 can affect
the integrity of the vascular basement membrane leading
to an aberrant organization of capillary structures
[10, 15, 17, 56]. Additionally, mice with mutations in the
basement membrane component Fibulin have abnormally
wide lung capillaries with normal capillary organization
[42]. Our Col4a1 and Col4a2 mutant mice likewise mani-
fested aberrant organization of the pulmonary microvas-
culature that was obvious 1 month after birth due to an
apparent abnormal angiogenesis. Pulmonary endothelial
growth is known to be essential for alveolar formation not
only in lung embryonic development [21, 37, 57–59], but
also in pulmonary alveolar regeneration [60]. Our work
shows that Col4a1 mutation in vascular endothelium is
sufficient to produce abnormalities in pulmonary micro-
vascular growth, to alter the alveolar endothelial–epithelial
association, and to cause alveolar epithelial developmental
deficiencies. More experiments are needed to address,
conversely, whether restricted type IV collagen mutation
in the epithelium will also direct abnormalities in the
association of the endothelium and epithelium of the
alveolar interface.
During alveologenesis the pulmonary saccules are
divided through serial septation, which increases the
surface area for gas exchange. Important players in
the process of septation are myofibroblasts anchored
in the alveolar basement membrane [26–28]. The expres-
sion of PDGFRα is decreased in Col4a1 mutants and both
PDGFRα+ and α-SMA+ alveolar myofibroblasts are dis-
placed in the interstitium of the embryonic Col4a1 and
Col4a2 mutants. The decrease of PDGFRα+ and α-SMA+
cells is also evident after birth. This suggests that type IV
collagen may be necessary for the correct spatial pattern-
ing of the alveolar myofibroblasts during septal formation
in part through the PDGFRα pathway. In Pdgfrα–/– mice
the alveolar myofibroblast spreading is compromised and
most PDGFRα+ cells remain in clusters at the bronchiolar
wall instead of being scattered throughout the alveolar
sacs [31]. In contrast to myofibroblasts, Col4a1 mutants
have an increase in lipofibroblasts. Recently, it has been
reported that the PDGFRα+ fibroblast lineage contributes
to the lipofibroblast pool in the mouse lung [61] and that
myofibroblasts and lipofibroblasts are characterized by
PDGFRαGFPbright/high and PDGFRαGFPdim/low expression
during alveolarization [62, 63].
In the presence of type IV collagen mutant protein,
both myofibroblast proliferation and migration were
negatively affected, while in vitro addition of type IV
collagen protein induced proliferation and migration in
α-SMA+ lung fibroblasts, confirming its important role.
(See figure on previous page.)
Fig. 7 Abnormal alveolar tropoelastin and elastin fiber accumulation. a At E18.5, tropoelastin expression in the developing septa in normal lungs
is detected at the tips (arrow) and throughout the interstitium (arrowhead). c By contrast, in Col4a1+/Δex41 lungs, tropoelastin expression shows a
patchy interstitial accumulation (arrowhead) with abnormal expression in the maldeveloped primary septa (arrow). b Hart’s staining marks the lung
elastin fibers at E18.5. Control lungs show well-defined thin elastin fibers (black) in the saccule spaces (arrowhead) and at the tip of developing primary
septa (arrow). d Saccule elastin fibers in Col4a1+/Δex41 mutants are interstitial and tortuous or fragmented at E18.5 (arrows). e Real-time PCR for Tropoelastin.
The expression of Tropoelastin is decreased in Col4a1+/Δex41 (Wilcoxon rank-sum test P < 0.07). Gapdh was used as a normalizer. f, g At P6, tropoelastin
is found at the tips of developing septa (arrow) and in elastin fibers (arrow). h, i Mutants show a decrease of tropoelastin (arrow) and abnormal
accumulation of elastin fibers at the septa tips (arrow). j At P30, while tropoelastin expression is localized at the tip of secondary septa marking the
myofibroblasts (arrow) and in the septal interstitium as a thin line (arrowhead). k In Col4a1+/Δex41 mutants, tropoelastin is localized diffusely throughout
the stumpy septal tips and in the interstitium of the secondary septa in a patchy pattern (arrow and arrowhead). l Tie2-Cre; Col4a1+/Flex41 lungs show
defined expression of tropoelastin at the tip of the lung septa as do normal lungs, but the septa are reduced in size (arrow). In addition, the less severe
Tie2-Cre; Col4a1+/Flex41 mutants show no tropoelastin localization in the interstitium (arrowhead). m After alveolarization, elastin fibers build up on the
tip of secondary septa (arrow). n In Col4a1+/Δex41, excessive accumulation of elongated elastin fibers is apparent (arrows). o In Tie2-Cre; Col4a1+/Flex41
elastin fibers are not elongated or ectopic in the interstitium (arrow) when compared to the abnormal elongation apparent in Col4a1+/Δex41 n. Scale
bars = 100 μm in a–d and f–l
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Alveolar myofibroblasts are the source of alveolar tro-
poelastin, which is an important regulator of alveologen-
esis when its expression levels are high [51]. α-SMA
expression in elastogenic alveolar myofibroblast cells
follows type IV collagen expression, and both precede
the expression of tropoelastin [51]. Interestingly, Col4a1
mRNA is expressed in the interstitium and at the tips of
alveolar septa in a pattern similar to tropoelastin.
Therefore, it is conceivable that type IV collagen regu-
lates elastogenesis specifically in the α-SMA+ cell popu-
lation. Earlier loss of type IV collagen directs loss of
alveolar myofibroblasts, tropoelastin, and causes aberrant
elastin fiber accumulation which may be the main cause
for the dramatic failure of saccular formation. By the end
of alveolarization in the mouse, at P30, lungs appear to
have excessive interstitial elastin fiber accumulation in
Fig. 8 In vitro epithelial–mesenchymal aggregations after COL4A treatment. a, b Control and type IV collagen-treated epithelial–mesenchymal
co-cultures. Septum-like formations are outlined. Type IV collagen treatment (5 μg/mL) results in bigger epithelial–mesenchymal aggregations.
c, f Localized PDPL expression is found in controls and, more highly expressed, in type IV collagen-treated co-cultures. d, g α-SMA staining is
dispersed throughout the co-cultures with clear accumulation of α-SMA+ of the co-culture aggregations. e, h Co-localization of PDPL and α-SMA.
i, j Staining of co-culture with COL4A shows increased accumulation of Col4a1-stained condensed fibers
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Col4a1+/Δex41 and R26-CreER; Col4a1+/Flex41 mice which is
likely due to ectopic elastin-producing α-SMA+ myofibro-
blasts localized in a patchy distribution in the lung inter-
stitium. It is also possible that the abnormal elastin fiber
accumulation may be a compensatory response to failure
of alveolar formation [32]. Tie2-Cre; Col4a1+/Flex41 lungs
lack this patchy interstitial distribution of α-SMA+ cells
and interstitial elastin fiber accumulation, suggesting a
direct effect of Col4a1 on alveolar myofibroblasts that is
independent of vascular type IV collagen.
There are four alpha integrins (ITGA) known to bind
to collagen type IV – ITGA1, ITGA2, ITGA10, ITGA11.
Among them, ITGA1 and ITGA2 have a higher affinity
for type IV collagen than ITGA2 and ITGA11 [64, 65].
ITGA2 is expressed in proximal and distal lung epithelium
co-localizing with pSPC (Additional file 9: Figure S9A, B),
and ITGA1 is expressed in the microvasculature by co-
staining with CD31. ITGA2 is also expressed in non-type
II cells, suggesting a role in other developmental processes
in the lung. ITGA11 has been reported to be expressed in
human lung interstitial fibroblasts [66], but we only
observed it in the proximal epithelium (data not shown).
Future investigation should be directed at uncovering the
molecular pathways by which integrins affect type IV col-
lagen regulation of the epithelium, vasculature and myofi-
broblasts during alveologenesis.
To address a direct effect of type IV collagen in septal
formation we used an in vitro co-culture of mesenchymal–
epithelial cells designed to resemble alveolar septal
formation [50]. A549 epithelial cells share properties with
immature alveolar type II pneumocytes but not of type I
pneumocytes (data not shown and [67, 68]). When A549
cells are co-cultured with lung fibroblasts, they express the
type I pneumocyte marker PDPL, which co-localizes with
α-SMA+ cells in type IV collagen treated co-cultures.
Endogenously produced type IV collagen fibers are also in-
creased in the cell aggregates found in treated co-cultures.
These aggregates may be due to cellular reorganization in
addition to epithelial–mesenchymal proliferation. Herein,
we demonstrated that type IV collagen signaling might in-
deed be important for the epithelial–mesenchymal inter-
action needed for septal formation.
In summary, we show that type IV collagen is essential for
alveolar lung patterning and propose a model (Fig. 9a, b) in
which type IV collagen regulates the epithelial and endo-
thelial components important for alveologenesis (Fig. 9c),
induces interstitial α-SMA myofibroblasts to proliferate
and migrate to the tip of the septa during early septation,
and later contributes to extension and final maturation of
secondary septa.
Conclusion
We conclude that type IV collagen is a key player in the
process of alveolar morphogenesis and is critical for the
proper formation of the BGB and the process of septation.
COL4A1 and COL4A2 mutations in humans cause multi-
system disorders in which pulmonary symptoms have not
been observed. However, Goodpasture syndrome, an auto-
immune disease in which antibodies attack the basement
membrane COL4A3 of lungs and kidneys, manifests lung
abnormalities ranging from symptoms as mild as a dry
cough and minor breathlessness to those with more severe
lung damage [11]. It is possible that mutations in COL4A1
and COL4A2 affecting the lung could go undetected, as
they would cause major developmental abnormalities
leading to early mortality.
Methods
Normal Chick embryos
Timed fertilized white leghorn eggs (SPAFAS, CT, USA)
were incubated in a humidified incubator (Khul, NJ) at
38 °C and staged by embryonic day (E) and managed as
previously described [69].
RNA isolation and double stranded cDNA synthesis
Total RNA was isolated from embryonic chick lungs har-
vested at embryonic days E14, E15, E16 (for each time
point n = 3), and E18 or E18.5 from Col4a1+/Δex41 mice
lungs (Controls n = 10 and Col4a1+/Δex41 = 10). RNeasy
Mini Kit (Qiagen, Valencia, CA, USA) was used to isolate
total RNA according to the manufacturer’s instructions.
Double stranded cDNA was synthesized from total chick
lungs RNA using a SuperScript Double-Stranded cDNA
Synthesis Kit (Life Technologies; Grand Island, NY, USA)
following the manufacturer’s instructions. All cDNA sam-
ples were tested for purity and integrity at Roche Applied
Science (Indianapolis, IN, USA) using a cDNA LabChip
on an Agilent 2100 Bioanalyzer prior to labeling.
Microarray processing and analysis
Chick samples were labeled by Roche Applied Science as
previously described [70]. After labeling, the samples (n = 3
for each time point) were hybridized for gene expression
analysis to a Gallus Gallus custom 12 × 135 K microarray
(NimbleGen Eukaryotic Gene Expression HD2 12-Plex
Array Delivery) which covers 22,000 open reading frames.
Microarray raw data was normalized by Robust Multi-
array Analysis and analyzed using DNASTAR ArrayStar
software package for analysis. One-way ANOVA was per-
formed at a 95 % confidence limit. The data discussed in
this publication have been deposited in NCBI’s Gene
Expression Omnibus [71] and are accessible through GEO
Series accession number GS72385 (https://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE72385).
Ontology assessment
The Gallus gallus transcript IDs were converted to their
murine homologous and named by Ensembl with
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BioMart (http://useast.ensembl.org/index.html). Once
the murine homologous gene list was generated, functional
classification of genes was performed using MGI and Vlad
(http://proto.informatics.jax.org/prototypes/vlad/).
Mouse type IV collagen models
Procedures were performed in accordance with
Institutional Animal Care and Use Committee guidelines
IACUC, protocol #AN102193-02B. Col4a1+/Δex41 (E16.5
n = 12; E18.5 n = 4; P6 n = 2; P30 n = 5), Col4a1+/G394V
(n = 3), and Col4a2+/G646D (n = 5) mutant mice were
described previously [45, 56]. To examine the role of
type IV collagen in alveologenesis, we used the inducible
conditional R26-CreER; Col4a1+/Flex41 mice in which dele-
tion of exon 41 of Col4a1 is induced by postnatal injection
of tamoxifen (which activates the CRE recombinase) in the
pups at birth [16]. Pups were injected with 50 μg of tam-
oxifen intragastrically (10 mg/mL; Sigma-Aldrich, St Louis,
MO) for three consecutive days. The vascular role of
Col4a1 in alveolar development was examined by the pre-
viously described vascular driven Tie2-Cre; Col4a1+/Flex41
mice [16]. Lungs from Tie2-Cre; Col4a1+/Flex41 (n = 5) or
Fig. 9 Schematic alveolar representation and suggested model for type IV collagen during alveologenesis. a Normal alveolar septum in which
type I (ATI) and II pneumocytes (ATII) cover the alveolar surface with the blood capillaries in close association. Alveolar myofibroblast progenitors
localized at the base of the septum proliferate, differentiate into alveolar myofibroblast, and migrate where they synthesize elastin. Lipofibroblasts
are localized close to ATII. b Type IV collagen mutations cause abnormal septum formation. Type IV collagen lungs have increased cells with lipid
content (ATII and lipofibroblasts), and abnormal capillary formation. Alveolar myofibroblasts fail to proliferate, differentiate and migrate, causing
defects in elastin deposition. c Suggested model for type IV collagen, basement membrane and septal myofibroblast development. Type IV
collagen is a central player in myofibroblast progenitor proliferation, differentiation and mobilization to the tip of the septum
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R26-CreER; Col4a1+/Flex41 (n = 5) mice were harvested
30 days after birth (P30) for analysis. All mutant mice ana-
lyzed were heterozygous.
Quantitative PCR
The RNA extracted previously for conducting microar-
rays from E14, E15, E16, and E18 (n = 3) chick lungs or
Col4a1+/Δex41 lungs from E18.5 normal (n = 11) and
Col4a1+/Δex41 (n = 10) mouse embryos were reverse-
transcribed to cDNA using superscript (Life Technolo-
gies, Grand Island, NY, USA) following the manufac-
turer’s protocol for RT-qPCR, which was carried out in
triplicate for each sample with IQ SYBR Green Supermix
(Biorad, Hercules, CA, USA) and gene-specific primers.
The data was analyzed using the ΔΔCt method on the
BioRad CFX manager v1.5. The most stable housekeeping
genes were selected by geNorm as normalizers for the
Real-Time PCR experiments: chick G6PDH: 5′CG
GGAACCAAATGCACTTCGT3′, 5′CGCTGCCGTAGA
GGTATGGGA3′ and mouse Gapdh: 5′GGGATGCA
GATCTTCGTGAAA3′; 5′CTTGCAGCAAAGATCAAC
CT3′. Chicken primers: COL4A1: 5′TGAAAGAGC
ACACGGTCAAG3′, 5′ATGGGTTCAGGAGTGGACA
G3′; and COL4a2: 5′CCGGGTCGCAGCGTTAGCAT3′,
5′AGCCAGCCAGCCCTAGGTCC3′. Mouse primers;
Cd31 5′GAAGTGTCCTCCCTTGAGCC′, 5′GGAGCCT
TCCGTTCTTAGGG3′; Tropoelastin: 5′CAGTTCCAC
TC3′, 5′GATTCGGCGTC3′; Nkx2.1: 5′CAGTTCCACT
CTGCAACGGA3′, 5′CGATTCGGCGTCGGCTGG3′;
Pdgfr-α: 5′CCGGGTCGCAGCGTTAGCAT3′, 5′AGCC
AGCCAGCCCTAGGTCC3′; pSpc: 5′TATGACTACCAG
CGGCTCCT3′, 5′CCAGCTTAGAGGTGGGTGTG3′;
α-Sma: 5′CCGGGTCGCAGCGTTAGCAT3′, 5′AGC
CAGCCAGCCCTAGGTCC3′; Sox9: 5′AGGAAGTCG
GTGAAGAACGG3′, 5′GGACCCTGAGATTGCCCAG
AA3′. RT-qPCR mRNA expression was analyzed by the
Wilcoxon rank-sum under the hypothesis of H1 = a < b.
We reasoned H1 as RT-qPCR assay followed protein cell
counting in which we already predicted that a < b (sup-
porting data are available in Additional file 10).
Tissue processing
Mouse embryos were fixed with 4 % paraformaldehyde
in RNAse-free PBS overnight at 4 °C. Fixed embryos and
harvested lungs were washed in PBS with 0.1 % Tween
20 (PBT) and either taken through a graded series of
methanol/PBT washes or stored at –20 °C in 100 %
methanol. General cytoarchitecture was primarily exam-
ined using H&E staining, on 5-μm paraffin sections pre-
pared by standard protocols [72]. For semi-thin sections,
lung samples were fixed in 4 % buffered glutaraldehyde
followed by dehydration in graded ethanol, and the
samples were embedded in a Polybed/Araldite 6500
mixture (Polysciences, Warrington, Pennsylvania,
USA). The 1-μm thick semi-thin sections were stained
with toluidine blue. The ultrathin sections were contrasted
with uranyl acetate and lead citrate and studied with an
H-7600 Hitachi electron microscope.
Immunohistochemistry
Immunohistochemical staining was performed using
standard techniques. Antigen retrieval was achieved by
heat treatment in a microwave oven for 20 min at low
power in 0.01 M sodium citrate buffer at pH 6. Before anti-
body incubation, peroxidase was quenched with H2O2.
Biotinylated secondary antibody (Vector Laboratories Inc.)
was used to localize antibody antigen complexes in the
ABComplex/HRP detection system (Dako, Carpinteria,
CA, USA) following the manufacturer′s directions. Anti-
gen detection was enhanced with 3,3’-diaminobenzidine
(Vector Laboratories Inc.). In tissue detected by fluores-
cence, secondary Alexa Fluor antibodies were used (Life
Technology, Grand island, NY, USA). The following
antibodies were used (full list of antibodies in the study):
anti-α-SMA (1:200; rabbit polyclonal; Abcam, Cambridge,
MA, USA), anti-prosurfactant protein C (1:400; rabbit
polyclonal; Abcam), anti-Ki67 (1:200; rabbit polyclonal;
Abcam), anti-mouse Ki67 (1:200; rat monoclonal; Affymetrix
eBioscience, San Diego, CA, USA), anti-CD31 (1:25; rabbit
polyclonal; Abcam), anti-PDGFR-α (1:50; rabbit poly-
clonal; SantaCruz, Dallas, TX, USA), anti-PDGFR alpha
(1:50; rabbit polyclonal; ThermoFisher, Cambridge, MA,
USA), anti-podoplanin (hamster monoclonal; SantaCruz),
anti-TTF1 (mouse monoclonal; SantaCruz), anti-SOX9
(rabbit polyclonal; a generous gift from Dr. de Santa
Barbara, University of Montpellier, France), anti-
tropoelastin (1:150; rabbit polyclonal; a generous gift
from Dr. Mecham, Washington University, St. Louis,
USA), anti-HOP (1:100; rabbit polyclonal; SantaCruz);
anti-E-Cadherin (1:100; mouse monoclonal; Abcam), anti-
macrophage MAC (1:100; mouse monoclonal; Abcam),
anti-ADFP (1:500; rabbit polyclonal; Novus Biologicals,
Littleton, CO, USA), anti-integrin α2 (1:50; mouse mono-
clonal; SantaCruz), anti-human integrin α1 (1:50; goat
polyclonal; R&D Systems, Minneapolis, MN, USA). Im-
ages were obtained using a Nikon Eclipse 80i microscope
at 20, 40, or 100× magnification, and Spot Imaging soft-
ware. Blinded epithelial cell counting was performed by
two different individuals and analyzed with the ImageJ
software. Epithelial counting was examined in a combin-
ation of Col4a1+/Δex41, Col4a1+/G394V and Col4a2+/G646D
(n = 3) and control (n = 3) in technical triplicated and by
two-tailed Student’s t test (supporting data are available in
Additional file 10).
In situ hybridization
A 561-bp segment of the Col4a1 transcript (uc009kvb.2)
was PCR amplified (PCR Master Mix, Promega, Madison,
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WI) with one set of exon-exon boundary overlapping
primers, designed using Primer-BLAST [73], hosted in the
National Center for Biotechnology Information (NCBI)
(http://www.ncbi.nlm.nih.gov/). The purified PCR fragment
was cloned into the pCR™II-TOPO® TA vector (TOPO®
TA Cloning® Kit, Dual Promoter) (ThermoFisher, Life
Technologies Corporation), and transformed into One
Shot® TOP10 Chemically Competent Cells (ThermoFisher,
Life Technologies Corporation). Transformed colonies on
agar plates were selected by ampicillin resistance after one
night at 37 °C. Sanger sequencing was used to determine
the orientation of the insert after linearization of the vector
with SpeI restriction digestion (New England Biolabs, Inc.).
Sense and anti-sense Digoxigenin-11-UTP labeled probes
(DIG RNA Labeling Mix, Sigma-Aldrich) were synthesized
with SP6 and T7 RNA polymerases, respectively. In situ
hybridization was performed using a technique minimally
altered from previously published protocols [74] and
developed using the BM purple AP substrate (Roche,
Indianapolis, USA) as per the manufacturer’s instructions.
Hart’s staining
Mice lung paraffin samples were dewaxed and incubated
with Hart’s stain for 1 h. After the samples were washed
with running tap water for 10 min and rinsed with
distilled water, they were counterstained with Van Gieson’s
Solution for 1 min. Samples were dehydrated in 95 %
alcohol, cleared in Xylene, and mounted for analysis.
Measurement of cell growth by methyl thiazol
tetrazolium (MTT) assay
Cell proliferation and viability assays were evaluated by
MTTassay; 96-well plates were coated with 0, 1 or 5 μg/mL
human type IV collagen recombinant protein for 2 hours at
room temperature (Millipore; Darmstadt, Germany).
Following the manufacturer’s directions (Lonza Group Ltd,
Basel, Switzerland), NHLFs were cultured at a density of
1000 cells/well in 100 μL growth medium and incubated at
37 °C, 5 % CO2 for 1, 3 and 5 days, when culture medium
was aspirated and 10 % MTT [7.5 mg/mL 1× PBS] was
added to the existing 100 μL growth FGM-2 media supple-
mented with FBS (Lonza, MD, USA). After incubation for
2 hours at 37 °C, the dissolving solution (70 % isopropanol,
0.028 % Triton-X 100, 0.0028 % HCL) was added for
15 min at room temperature. Absorbance at 595 nm was
measured using a microplate reader (Molecular Devices,
Sunnyvale, CA, USA). Experiments were conducted in
technical triplicate and analyzed by two-tailed Student’s
t test (supporting data are available in Additional file 10).
Migration assay
Between 5000 and 6000 NHLF cells expressing α-SMA
were plated in 12-well plates with silicone culture inserts
(Ibidi, GmbH, Planegg, Germany) for 48 hours with
either 5 μg/mL type IV collagen protein or 0.5 M
acetic acid as a control. Inserts were removed, fresh
treatment added, and cell migration monitored during
24 hours. Images of the different time points captured
on a Nikon DS-QiMc camera using NIS-Elements BR
3.0. Quantification of cell invasion into the insert
space was performed and compared using ImageJ soft-
ware. Experiments were conducted three times (n = 3)
in triplicate. Gap cell invasion was analyzed by two-tailed
Student’s t test.
Epithelial–mesenchymal co-culture
Human embryonic lung fibroblast MRC-5 cells (ATCC,
VA, USA) and human lung carcinoma epithelial A549
cells (ATCC) were cultured in either DMEM or EMEM
with 10 % FBS at 37 °C and 5 % CO2. Co-culture experi-
ments followed published protocols [50] with minor
modifications. Briefly, MRC-5 fibroblast cells were plated
at high density and grown to confluence in EMEM for
5–6 days. A549 epithelial cells were added to MRC-5
cells at high density (250,000 cells per well in a 12-well
plate) to ensure full coverage over the underlying MRC-5
cells. Co-culture was maintained in DMEM with 10 %
FBS and changed to 2 % after plaiting the A549 cells.
Type IV collagen protein (5 μg/mL; EMD Millipore,
Billerica, MA, USA) was added in solution after overnight
attachment of A549 cells. Type IV collagen was added
fresh every 2 days. After 5 days of treatment, samples were
fixed, immunolabeled for alveolar markers and mounted
for imaging using standard techniques. Nuclei were
labeled with DAPI (Vectashield; Vector Laboratories
Inc., Burlingame, CA, USA). Images were obtained using
Nikon Eclipse TS100 at 4× magnification using NIS-
Elements BR 3.0. Experiments were conducted in triplicate.
Additional files
Additional file 1: Figure S1. Heatmap and volcano plot of microarray
data. (A) Heatmap of differentially expressed genes across the four time points.
Samples cluster according to time point (blue: E18, green: E16, red: E14 and
yellow: E15). The unsupervised hierarchical clustering of all the transcripts
forms six discrete groups. From top to bottom, cluster A (n = 190 chick
transcripts) contains genes involved in neurogenesis, neuron differentiation
and neuron projection morphogenesis; cluster B (n = 206) is enriched for
hemostasis, coagulation and immune system process genes; cluster C (n = 42)
contains various genes involved in miscellaneous processes; cluster D
(n = 119) is characterized by angiogenesis, vascular development, endothelial
and smooth muscle proliferation genes; cluster E (n = 84) groups genes,
mostly transcription factors, with a role in organogenesis. Finally, cluster F
(n = 18, indicated by the red asterisk) contains a limited number of genes
involved in blood vessel morphogenesis and includes Adam12, Col4a1, Col4a2,
Crmp1, Emp1, Epas1, Fbln5, Meis1, Mgp, Podxl, Snai2, and Wnt11. GO
enrichment analyses were computed by the Panther Classification System,
available at http://geneontology.org. GO annotations were retrieved after
one-to-one conversion of chick to mouse orthologs by Ensembl Biomart,
accessible at http://www.ensembl.org/biomart/martview. (B) A volcano plot
was used to compare fold change from E14 to E18 of log2 normalized data
(x-axis) and –log10 of the adjusted P value across the four time points,
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computed by limma. Transcripts with adjusted P values less than or equal to
0.05 and fold change greater than, or equal to, 1 are shown in green. The
Col4a1 and Col4a2 transcripts are indicated by the red and blue squares
(top right), respectively. (C) Bi-plot of the Principal Component Analysis results,
conducted using the prcomp function to identify potential sample outliers.
(TIF 16074 kb)
Additional file 2: Figure S2. Histology and immunohistochemistry
analyses of the distal epithelium of Col4a1+/G394V and Col4a2+/G646D
mutants. (A, B) Hematoxylin and eosin staining shows thickened
interstitium and the small primitive alveolar sacs in Col4a1 and Col4a2
mutant lungs. Immunohistochemistry of NKX2.1 (C, D), SOX9 (E, F) and
PSPC (F, G) in Col4a1+/G394V and Col4a2+/G646D display clusters of the distal
epithelium. Scale bars = 200 μm in A to G. (TIF 24701 kb)
Additional file 3: Figure S3. (A–D) Histology of R26-CreER; Col4a1+/Flex41
and Tie2-Cre; Col4a1+/Flex41 mutants, and (E–I) immunohistochemistry analysis
of PDPL-pSPC, HOPX, α-SMA, tropoelastin, and elastin in R26-CreER;
Col4a1+/Flex41. (A, B) Hematoxylin and eosin shows that both R26-CreER;
Col4a1+/Flex41 and Tie2-Cre; Col4a1+/Flex41 mutants have simplified
alveolarization. (C) R26-CreER; Col4a1+/Flex41 septa are thick and with
numerous blood capillaries (arrowheads) and cells with lipid content
(arrows). (D) Tie2-Cre; Col4a1+/Flex41 septa are small and short with increases
in blood capillaries (arrowheads), but not in cells with lipid content. (E) pSPC
and PDPL co-staining shows a disorganized alveolar epithelium. (F) R26-CreER;
Col4a1+/Flex41 display a decrease of type I pneumocytes as shown by nuclear
staining of HOPX. (G–I) Abnormal localization of α-SMA, tropoelastin and
elastin in the septa of R26-CreER; Col4a1+/Flex41 lungs. Scale bars = 200 μm in A
and B, 35 μm in C and D, 50 μm in E, and 100 μm in F to I. (TIF 24706 kb)
Additional file 4: Figure S4. Immunofluorescence of pSPC, ADFP and
MAC in Col4a1+/Δex41, R26-CreER; Col4a1+/Flex41, and Tie2-Cre; Col4a1+/Flex41.
(A, D, G–J) pSPC normal localization at P6 (A) and P30 (G) is spread
throughout the lung alveoli, while in P6 and P30 Col4a1+/Flex41 (D, H) and
in P30 R26-CreER; Col4a1+/Flex41 (I) it is patchy and a slightly increased. This
patchy Col4a1+/Δex41 and R26-CreER; Col4a1+/Flex41 distribution of pSPC is
not observed in Tie2-Cre; Col4a1+/Flex41 (J). (E, L, M) Lipofibroblast staining with
ADFP marker shows increased of ADFP+ cells in P6 and P30 Col4a1+/Δex41
(E, L) and in P30 R26-CreER; Col4a1+/Flex41 (M) lungs compared with normal
lungs (B, K). (N) Tie2-Cre; Col4a1+/Flex41 displays decreased ADFP+ cells. (C, F)
Decrease of MAC+ cells in Col4a1+/Δex41 (F) at P6, but not as clear at P30 (O–R).
Scale bars = 200 μm in A to J and O to R, 100 μm in K to N. (TIF 24708 kb)
Additional file 5: Figure S5. (A–F) Immunohistochemistry analyses of
E16.5 Col4a1+/Δex41. (A, B) Double immunofluorescence Ki67 and NKX2.1
in Col4a1+/Δex41 and wild type lungs show no differences in overall
proliferation. Mutants display no differences in SOX9 (C, D), pSPC and
NKX2.1 (E, F), CD31 and NKX2.1 (G, H), α-SMA and E-CAD (I, J), or HOPX (K, L)
localization. Scale bars = 100 μm in A and B, 200 μm in C to L. (TIF 24679 kb)
Additional file 6: Figure S6. Immunofluorescence of PDPL and CD31
Col4a1+/G394V, Col4a2+/G646D mutants, and R26-CreER; Col4a1+/Flex41. (A, B) PDPL
and CD31 staining shows vascular disorganization around collapse saccules
in Col4a1+/G394V (A) and Col4a2+/G646D (B). This disorganization is also observed
in P30 R26-CreER; Col4a1+/Flex41 (C, D). Scale bars = 100 μm in A and B, 200 μm
in C. (TIF 24703 kb)
Additional file 7: Figure S7. Immunohistochemistry of PDGFRα, α-SMA,
tropoelastin, and elastin in Col4a1+/G394V and Col4a2+/G646D lungs. Col4a1
and Col4a2 mutant lungs exhibit a decreased and patchy distribution of
PDGFRα (A, B), SMA-α (C, D), and tropoelastin expression (E, F). Elastin
fibers are atypical and decreased in Col4a1+/G394V (G) and Col4a2+/G646D
(H) lungs. Scale bars = 100 μm in A to H. (TIF 24703 kb)
Additional file 8: Figure S8. PDGFRα localization in P30 mutant lungs.
(A–D) At P30, Col4a1+/Δex41 (B) has fewer PDGFRα+ cells compared to
normal (A), R26-CreER; Col4a1+/Flex41 (C) and Tie2-Cre; Col4a1+/Flex41 (D) lungs.
Scale bars = 100 μm in A to D. (TIF 24700 kb)
Additional file 9: Figure S9. (A, C) ITGA2 and ITGA1 localization in
normal lungs. (A–C) During development, at E18.5, ITGA2 displays
epithelial localization that partially co-localizes with pSPC (A, B). At P30,
ITGA1 expression is co-stained with CD31, marking the vasculature (C).
Scale bars = 100 μm in A–C. (TIF 24700 kb)
Additional file 10. Supporting data. (XLSX 14 kb)
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